Publications by authors named "Moataz Yousry Soliman"
Article Synopsis
- The study aimed to evaluate the link between non-alcoholic fatty liver disease (NAFLD) and various cardiovascular issues, including angina and heart attacks.
- A thorough review of existing research included 32 studies with over 5.6 million participants, finding that NAFLD significantly increases the risk of several cardiovascular problems.
- The results highlight the need for better prevention and management strategies for NAFLD, even after considering traditional risk factors for heart disease.
Background & Aims: This research aimed to determine how variations in the vitamin D receptor gene affected the response of infections to eradication therapy.
Patients And Methods: On 105 adult -positive patients, a prospective cohort study was carried out. PCR was used to genotype all patients' VDR gene polymorphisms.
Background & Aims: The utility of ultrasound and color Doppler in the diagnosis and evaluation of inflammatory bowel diseases (IBD) has not been studied enough. Therefore, the aim of the current study was to evaluate the importance of conventional abdominal ultrasound and color Doppler in diagnosing IBD and assessing disease activity.
Methods: The study was conducted at the National Hepatology and Tropical Medicine Research Institute (NHTMRI) between July 2018 and January 2019, in which 150 patients were suffering from diarrhea, dysentery, tenesmus, or rectal bleeding were evaluated by colonoscopy, high-resolution ultrasound, and color Doppler scans.
Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience.
Medicine (Baltimore)
October 2020
Treatment of hepatitis C virus (HCV) infection in patients with chronic kidney disease was difficult in the past because of the use of interferon (IFN). It was associated with high risk IFN-related adverse reactions due to reduced renal clearance of IFN. This study aimed to evaluate the antiviral efficacy, safety, and tolerability of ombitasvir/paritaprevir/ritonavir/ribavirin in chronic kidney disease patients infected with chronic HCV.
View Article and Find Full Text PDF